Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

T1DM - Type 1 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongshan Hospital, Fudan University, Shanghai, China
Contact: Study coordinator (Jingjing JIANG, MD, PhD) · jiang.jingjing@zs-hospital.sh.cn · 86-021-64041990
Contact: Principal Investigator (HUIJIE ZHANG, MD, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Simultaneous Measurement and Responsive Treatment - Part 2

Type 1 Diabetes Mellitus · T1D · Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Toronto, Canada

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy · Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE1

Neuss, Germany

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Type 1 Diabetes

Abroad (travel likely)RecruitingEARLY_PHASE1

Nashville, United States

The Effects of Fluoxetine and/or DHEA

Type 1 Diabetes Mellitus

Abroad (travel likely)RecruitingEARLY_PHASE1

Baltimore, United States